Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
12.24
0.52 (4.44%)
At close: Aug 15, 2025, 3:59 PM
12.74
4.08%
After-hours: Aug 15, 2025, 07:47 PM EDT
Atara Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 17.57M | 98.15M | 32.75M | 40.19M | 28.64M | 27.36M | 4.25M | 2.14M | 957K | 1.23M | 221K | 4.46M | 51.58M | 7.31M | 7.55M | 5.37M | 3.87M | 3.55M |
Cost of Revenue | 554K | 20.44M | 6.79M | 7.6M | 4.63M | 1.99M | 3.16M | 2.62M | 2.9M | 216K | 4.07M | 4.14M | 64.9M | 2.23M | 3.18M | 70.33M | 68.47M | 2.6M |
Gross Profit | 17.02M | 77.71M | 25.96M | 32.59M | 24.01M | 25.37M | 1.09M | -477K | -1.94M | 1.01M | -3.85M | 318K | -13.32M | 5.09M | 4.36M | -64.96M | -64.61M | 957K |
Operating Income | 3.2M | 38.8M | -12.2M | -21.76M | -18.23M | -26.5M | -53.28M | -69.61M | -71.41M | -75.02M | -75.54M | -84.62M | -32.13M | -88.22M | -95.89M | -84.81M | -84M | -78.25M |
Interest Income | 143K | 236K | 597K | 459K | 450K | 604K | 711K | 1.22M | 1.7M | 1.8M | 1.99M | 973K | 704K | 228K | n/a | n/a | n/a | n/a |
Pretax Income | 2.39M | 38.01M | -12.71M | -21.93M | -19.05M | -31.73M | -60.44M | -69.82M | -71.11M | -74.75M | -74.57M | -84.08M | 18.47M | -88.11M | -93.32M | -84.66M | -83.78M | -78.33M |
Net Income | 2.39M | 38.01M | -12.69M | -21.91M | -19.05M | -317.52M | -604.5M | -697.97M | -711.08M | -747.71M | -745.72M | -840.91M | 184.66M | -881.05M | -933.49M | -846.64M | -837.93M | -783.35M |
Selling & General & Admin | 5.93M | 11.47M | 9.44M | 10.42M | 8.91M | 9.76M | 10.39M | 12.25M | 13.34M | 13.87M | 13.24M | 18.92M | 18.81M | 20.57M | 21.82M | 19.85M | 19.4M | 17.74M |
Research & Development | 7.31M | 27.43M | 28.72M | 43.92M | 33.33M | 42.11M | 43.98M | 56.89M | 56.14M | 62.16M | 62.52M | 70.16M | 64.9M | 74.96M | 79.13M | 70.33M | 68.47M | 64.06M |
Other Expenses | 579K | n/a | n/a | n/a | n/a | 68K | -12K | -27K | -10K | -197K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.82M | 38.91M | 38.16M | 54.34M | 42.24M | 51.87M | 54.37M | 69.14M | 69.48M | 76.03M | 75.76M | 89.08M | 83.71M | 95.53M | 100.95M | 90.18M | 87.87M | 81.8M |
Interest Expense | 972K | 1.02M | 1.02M | 1.18M | 1.26M | 1.15M | 1.18M | 1.4M | 1.38M | 1.34M | 969K | 123K | 129K | 4K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -1.36M | -1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.38M | 59.35M | 44.96M | 61.95M | 46.87M | 53.85M | 57.53M | 71.75M | 72.37M | 76.24M | 75.76M | 89.08M | 83.71M | 95.53M | 100.95M | 90.18M | 87.87M | 81.8M |
Income Tax Expense | 3K | n/a | -19K | -17K | n/a | 24K | 11K | -19K | 1K | 22K | 2K | 10K | -50.6M | -115K | 30K | -541K | 16K | -373K |
Shares Outstanding (Basic) | 12.2M | 10.76M | 10.69M | 7.47M | 6.14M | 5.62M | 4.33M | 4.26M | 4.2M | 4.16M | 4.13M | 4.1M | 4.1M | 4.03M | 3.9M | 3.74M | 3.68M | 3.66M |
Shares Outstanding (Diluted) | 12.31M | 10.85M | 10.69M | 7.47M | 6.14M | 5.62M | 4.33M | 4.26M | 4.2M | 4.16M | 4.13M | 4.1M | 4.07M | 4.03M | 3.9M | 3.74M | 3.69M | 3.66M |
EPS (Basic) | 0.20 | 3.53 | -1.19 | -2.93 | -3.1 | -5.65 | -13.98 | -16.4 | -16.91 | -17.98 | -18.07 | -20.53 | 4.54 | -21.87 | -23.96 | -22.61 | -22.73 | -21.41 |
EPS (Diluted) | 0.19 | 3.50 | -1.19 | -2.93 | -3.1 | -5.65 | -13.98 | -16.4 | -16.91 | -17.98 | -18.07 | -20.53 | 4.50 | -21.87 | -23.96 | -22.61 | -22.75 | -21.41 |
EBITDA | 3.6M | 40.82M | -10.6M | -19.51M | -16.46M | -29.18M | -58.06M | -67.19M | -68.53M | -69.32M | -74.28M | -82.59M | -30.69M | -86.51M | -90.92M | -82.5M | -81.68M | -76.02M |
EBIT | 3.36M | 39.03M | -11.7M | -20.74M | -17.79M | -30.57M | -59.26M | -68.39M | -69.73M | -73.41M | -75.54M | -83.96M | 18.59M | -88.1M | -93.4M | -84.81M | -84M | -78.25M |
Depreciation & Amortization | 236K | 1.79M | 1.1M | 1.23M | 1.33M | 1.39M | 1.21M | 1.21M | 4.15M | 4.09M | 4.07M | 4.14M | 4.21M | 2.23M | 3.18M | 2.86M | 2.72M | 2.6M |